Lee Kee Holdings Limited (637) Announces Interim Results for 2025, Reports HK$920.7 Million Revenue

Bulletin Express
2025/11/14

Lee Kee Holdings Limited (“LEE KEE”, Stock Code: 637) released its unaudited interim results for the six months ended 30 September 2025. Revenue amounted to approximately HK$920.7 million, compared with HK$1,007.6 million in the same period last year. The quantity of metal products sold reached about 39,300 tonnes, down from around 43,100 tonnes a year ago.

Gross profit stood at HK$41.9 million, slightly above HK$39.6 million in the previous year’s comparable period. The Group recorded a loss attributable to equity shareholders of about HK$10.2 million, narrowing from the HK$18.0 million loss posted in the prior year. Basic loss per share was 1.23 Hong Kong cents, compared to 2.17 Hong Kong cents a year earlier.

The interim report highlighted disciplined cost controls, a more favorable product mix, and stable demand in selected sectors. Attention to testing and consultancy services contributed to other income of HK$8.9 million, up from HK$7.1 million in the previous year. Distribution and administrative expenses both remained generally flat, at HK$12.0 million and HK$46.0 million respectively.

Cash and cash equivalents were reported at HK$239.4 million, alongside total bank borrowings of HK$2.9 million. This led to a gearing ratio of 1.15%. The Group also has in place a land-resumption agreement related to Genesis Alloys (Ningbo) Limited, valued at approximately HK$14.3 million in compensation and relocation bonus.

The Board did not recommend payment of an interim dividend for this period. As of 30 September 2025, the Group employed 190 staff members. Company management reiterated that it will focus on product innovation, operational efficiency, and environmental initiatives to address ongoing market uncertainties in the non-ferrous metals sector.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10